Literature DB >> 19088261

Tocilizumab for multirefractory adult-onset Still's disease.

M De Bandt, B Saint-Marcoux.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19088261     DOI： 10.1136/ard.2008.088179

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  20 in total

Review 1.  A case of refractory adult-onset Still's disease successfully controlled with tocilizumab and a review of the literature.

Authors:  Katja Perdan-Pirkmajer; Sonja Praprotnik; Matija Tomšič
Journal:  Clin Rheumatol       Date:  2010-08-24       Impact factor: 2.980

Review 2.  Macrophage activation syndrome complicating rheumatic diseases in adults: case-based review.

Authors:  Mayan Gilboa; Gil Bornstein; Ilan Ben-Zvi; Chagai Grossman
Journal:  Rheumatol Int       Date:  2019-07-31       Impact factor: 2.631

Review 3.  Successful treatment of adult-onset Still's disease with tocilizumab monotherapy: two case reports and literature review.

Authors:  Ryota Sakai; Hayato Nagasawa; Eiko Nishi; Ayumi Okuyama; Hirofumi Takei; Takahiko Kurasawa; Tsuneo Kondo; Koji Nishimura; Yuichiro Shirai; Tatsuya Ito; Hideto Kameda; Tsutomu Takeuchi; Koichi Amano
Journal:  Clin Rheumatol       Date:  2012-01-04       Impact factor: 2.980

4.  Etanercept-refractory adult-onset Still's disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab.

Authors:  Keiichi Sumida; Yoshifumi Ubara; Junichi Hoshino; Tatsuya Suwabe; Rikako Hiramatsu; Eiko Hasegawa; Noriko Hayami; Masayuki Yamanouchi; Naoki Sawa; Fumi Takemoto; Kenmei Takaichi
Journal:  Clin Rheumatol       Date:  2010-03-12       Impact factor: 2.980

5.  Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease.

Authors:  Taio Naniwa; Rei Ito; Maiko Watanabe; Yoshihito Hayami; Shinji Maeda; Kaneshige Sasaki; Shiho Iwagaitsu
Journal:  Clin Rheumatol       Date:  2010-09-15       Impact factor: 2.980

6.  Correlation of serum CX3CL1 level with disease activity in adult-onset Still's disease and significant involvement in hemophagocytic syndrome.

Authors:  Tsuyoshi Kasama; Hidekazu Furuya; Ryo Yanai; Kumiko Ohtsuka; Ryo Takahashi; Nobuyuki Yajima; Yusuke Miwa; Kazuo Kobayashi
Journal:  Clin Rheumatol       Date:  2012-02-10       Impact factor: 2.980

Review 7.  Genetics of asthma susceptibility and severity.

Authors:  Rebecca E Slager; Gregory A Hawkins; Xingnan Li; Dirkje S Postma; Deborah A Meyers; Eugene R Bleecker
Journal:  Clin Chest Med       Date:  2012-07-07       Impact factor: 2.878

Review 8.  Treatment of refractory adult-onset Still's disease with tocilizumab: report of two cases and review of the literature.

Authors:  Rene Thonhofer; Manuela Hiller; Horst Just; Markus Trummer; Cornelia Siegel; Christian Dejaco
Journal:  Rheumatol Int       Date:  2011-01-15       Impact factor: 3.580

Review 9.  An Update on the Pathogenic Role of Macrophages in Adult-Onset Still's Disease and Its Implication in Clinical Manifestations and Novel Therapeutics.

Authors:  Po-Ku Chen; Der-Yuan Chen
Journal:  J Immunol Res       Date:  2021-06-20       Impact factor: 4.818

Review 10.  Targeting interleukin-6: all the way to treat autoimmune and inflammatory diseases.

Authors:  Toshio Tanaka; Tadamitsu Kishimoto
Journal:  Int J Biol Sci       Date:  2012-10-24       Impact factor: 6.580
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.